2012 Fiscal Year Final Research Report
Development of a novel inotropic and lucitorpic agent for treatment of heart failure
Project/Area Number |
22390050
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
General pharmacology
|
Research Institution | Yamaguchi University |
Principal Investigator |
INUI Makoto 山口大学, 大学院・医学系研究科, 教授 (70223237)
|
Co-Investigator(Kenkyū-buntansha) |
HONDA Takeshi 山口大学, 大学院・医学系研究科, 講師 (30457311)
KURAMASU Atsuo 山口大学, 大学院・医学系研究科, 准教授 (90302091)
|
Project Period (FY) |
2010 – 2012
|
Keywords | ホスホランバン / アプタマー / 心筋小胞体 / 心不全治療薬 |
Research Abstract |
We developed a phospholamban specific RNA aptamer as a novel inotropic and lucitropic agent to treat heart failure. The obtained aptamer increased Ca2+ uptake by cardiac sarcoplasmic reticulum in the nanomolar range. To introduce it into cardiomyocytes, we conjugated a membrane penetrating peptide to the aptamer. This aptamer facilitated contraction as well as relaxation of isolated cardiomyocytes. Furthermore, the aptamer improved cardiac functions in vivo. A membrane penetrating peptide-conjugated phospholamban aptamer is thus a potent inotropic and lucitropic agent and could be a novel drug for heart failure.
|
Research Products
(7 results)
-
-
-
-
[Journal Article] Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling2012
Author(s)
Miyazaki, Y., Ikeda, Y., Shiraishi, K., Fujimoto, S. N., Aoyama, H., Yoshimura, K., Inui, M., Hoshijima, M., Kasahara, H., Aoki, H., and Matsuzaki, M
-
Journal Title
PloS one
Volume: 7
Pages: e35875
DOI
Peer Reviewed
-
[Journal Article] Isoform-specific role of protein phosphatase 1 catalytic subunits in sarcoplasmic reticulum-mediated Ca^2+cycling2011
Author(s)
Aoyama, H., Ikeda, Y., Miyazaki, Y., Yoshimura, K., Nishino, S., Yamamoto, T., Yano, Y., Inui, M., Aoki, H., and Matsuzaki, M
-
Journal Title
Cardiovasc. Res
Volume: 89
Pages: 79-89
DOI
Peer Reviewed
-
-